Sign In
Buy TEVA
$34.43
-0.0300 (-0.0871%)
At Close: Aug 04, 2026
Clifford Swan Investment Counsel Llc Buys Kyndryl Holdings Inc, Vanguard Total World Stock ETF, ...
04:38pm, Friday, 11'th Feb 2022 GuruFocus
Related Stocks: ACWI , VT , AGG , SPAB , SSD , BKNG , KD , PDI , FDX , TTD , FELE , AMAT , GIM , DFAT , SPG , PCAR , TEVA ,
Teva Pharmaceutical Industries Limited 2021 Q4 - Results - Earnings Call Presentation
02:27pm, Friday, 11'th Feb 2022 Seeking Alpha
Court affirms Teva win in fight over generic Narcan anti-overdose drug
07:42pm, Thursday, 10'th Feb 2022 Reuters
Teva Pharmaceuticals has again defeated arguments that its generic version of the anti-overdose nasal spray Narcan violates patents on the drug, persuading a U.S. appeals court on Thursday to reject a lawsuit by Narcan maker Adapt Pharma.
Teva''s Copaxone gets approval in EU for use in breastfeeding mothers with MS
06:24pm, Thursday, 10'th Feb 2022 Seeking Alpha
Teva Pharmaceuticals <> Europe BV said Copaxone (Glatiramer Acetate ((GA)) injection) 20mg/mL and 40mg/mL, was approved by EU health authorities for use in breastfeeding…
TEVA Stock Up on Q4 Earnings Beat, Sales Miss Estimates
04:43pm, Thursday, 10'th Feb 2022 Zacks Investment Research
Shares of TEVA rise 8.4% after the company beat earnings estimates despite missing on sales for fourth-quarter 2021. It issues its financial guidance for 2022.
Teva Pharmaceutical Industries (TEVA) Q4 2021 Earnings Call Transcript
01:30pm, Thursday, 10'th Feb 2022 The Motley Fool
TEVA earnings call for the period ending December 31, 2021.
Teva Pharmaceutical Industries (TEVA) Q4 2021 Earnings Call Transcript
01:30pm, Thursday, 10'th Feb 2022 The Motley Fool
TEVA earnings call for the period ending December 31, 2021.
TEVA Stock Up on Q4 Earnings Beat, Sales Miss Estimates
01:05pm, Thursday, 10'th Feb 2022
Shares of TEVA rise 8.4% after the company beat earnings estimates despite missing on sales for fourth-quarter 2021. It issues its financial guidance for 2022.
Teva eyes up to $3.6 billion to settle opioid claims - Reuters
11:48am, Thursday, 10'th Feb 2022 Seeking Alpha
Teva Pharmaceutical (TEVA) ADRs are trading ~1% lower in the pre-market on Thursday after Reuters reported that the generic drugmaker is bracing to spend as much as $3.6B in cash
Teva Pharmaceutical Industries Ltd. (TEVA) CEO Kåre Schultz on Q4 2021 Results - Earnings Call Transcript
05:43pm, Wednesday, 09'th Feb 2022 Seeking Alpha
Teva Pharm may pay as much as $3.6 billion in U.S. opioid settlement
04:58pm, Wednesday, 09'th Feb 2022 Reuters
Teva Pharmaceutical Industries said on Wednesday it was bracing to pay as much as $3.6 billion in cash and medicine to settle lawsuits alleging it was one of a number of drugmakers and distributors that fuelled the U.S. opioid epidemic.
Thinking about buying stock in Zosano Pharma, Banco Bradesco, AMC Entertainment, Snap, or Teva Pharmaceutical?
03:50pm, Wednesday, 09'th Feb 2022 Benzinga
NEW YORK, Feb. 9, 2022 /PRNewswire/ Full story available on Benzinga.com
Why Are Teva Pharmaceutical Shares Trading Higher Today?
03:26pm, Wednesday, 09'th Feb 2022 Benzinga
Teva Pharmaceutical Industries Ltd''s (NYSE: TEVA ) Q4 sales reached $4.1 billion , shrinking 8% Y/Y, missing the consensus of $4.29 billion. The decrease is mainly due to lower revenues from generic products in North America and COPAXONE, partially offset by higher revenues from AUSTEDO and AJOVY. Revenues continued to be affected by the ongoing impact of the COVID-19 pandemic Full story available on Benzinga.com
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement
02:57pm, Wednesday, 09'th Feb 2022
Teva CEO Kåre Schultz joins 'The Exchange' to discuss Covid's impact on patient behavior.
The Struggles Continue For Generic Drugs Behemoth Teva Pharmaceutical
01:57pm, Wednesday, 09'th Feb 2022 Investor''s Business Daily
Teva Pharma reported lighter-than-expected sales Wednesday as its generic drugs business and Copaxone continued to struggle. Teva stock fell.
